HUTCHMED (China) (HMDCF) Research & Development (2018 - 2021)

HUTCHMED (China) (HMDCF) has reported Research & Development for 4 consecutive years, with -$66.0 million the latest figure, recorded in Q2 2021.

• On a quarterly basis, Research & Development fell 51.83% year-over-year to -$66.0 million in Q2 2021; TTM through Jun 2021 was -$197.0 million, a 37.9% decrease from a year earlier, with the FY2025 full-year figure at -$148.3 million, up 30.09% from the prior year.
• Research & Development was -$66.0 million for Q2 2021 at HUTCHMED (China), down from -$57.1 million in the prior quarter.
• Over five years, Research & Development peaked at $88.7 million in Q2 2018 and troughed at -$102.6 million in Q2 2019.
• A 4-year average of -$18.4 million and a median of -$31.0 million in 2019 frame the typical range for Research & Development.
• The widest YoY moves for Research & Development: up 216.11% in 2019, down 247.29% in 2019.
• Over 4 years, Research & Development stood at $25.4 million in 2018, then slumped by 247.29% to -$37.5 million in 2019, then dropped by 16.04% to -$43.5 million in 2020, then tumbled by 51.83% to -$66.0 million in 2021.
• The last three Research & Development figures came in at -$66.0 million (Q2 2021), -$57.1 million (Q1 2021), and -$43.5 million (Q2 2020), per Business Quant data.